Abstract:Background Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance and progressive vascular remodeling. Our recent study for the first time demonstrated that loss of hypoxia inducible factor (HIF) prolyl‐4 hydroxylase 2 (PHD2) in endothelial cells and bone marrow cells in mice induces severe PAH with obliterative pulmonary vascular remodeling and plexiform‐like lesions recapitulating clinical PAH. Increased oxidative/nitrative stress is a hall marker of clinical PAH and Caveolin‐1 (Cav1) is an important regulator of oxidative/nitrative stress and the pathogenesis of clinical PAH. It is unclear whether Cav1 deficiency and nitrative stress are involved in the pathogenesis of severe PAH in this mouse model. Methods Mice with Tie2 Cre‐mediated disruption of Egln1 (encoding PHD2) ( Egln1 CKO ), Egln1 and Hif2a ( EH2 DKO), and mice with Egln1 disruption and Cav1 transgene (expressing Cav1 in endothelial cells) ( Egln1 CKO/Tg) were generated. Western blotting and immunostaining were performed to quantify nitration stress and Cav1 expression. MnTMPyP (a superoxide scavenger) and Tempol (a radical scavenger) were administrated to Egln1 CKO mice. Right ventricular systolic pressure (RVSP) and RV/(LV+S) ratio, indicator of RV hypertrophy, were measured. Pulmonary vascular remodeling were assessed by histological examination. Echocardiography was used to measure RV and PA function. Results Nitrotyrosine was markedly increased in Egln1 CKO mouse lungs and normalized in EH2 DKO mouse lungs. Both MnTMPyP and Tempol treatment inhibited RVSP increase and RV hypertrophy, and decreased medial thickness and muscularization of distal pulmonary arterials in Egln1 CKO mice. Mechanistically, endothelial Cav1 expression was decreased in Egln1 CKO mouse lungs and normalized in EH2 DKO mice. Restored Cav1 expression in Egln1 CKO /Tg mice inhibited RVSP and RV hypertrophy and resulted in normalization of RV and PA function and pulmonary vascular remodeling. Both pharmacological and genetic approaches promoted survival of Egln1 CKO mice. Conclusion These data show that loss of endothelial PHD2 suppresses Cav1 expression in a HIF‐2α dependent manner. Decrease of Cav1 expression and resultant activation of nitrative stress contribute to the severe vascular remodeling and PAH in Egln1 CKO mice. Thus, targeting nitrative stress and restoring Cav1 expression are potentially effective approaches for treatment of PAH. Support or Funding Information NIH grants R01HL123957, R01HL125350, R01HL133951, and P01HL077806 (Project 3) to Y.Y.Z, AHA postdoctoral fellowship grant 15POST25700124 to Z.D.

Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice

Abstract 196: DDAH1 Knockout Exacerbates Hypoxia-induced Pulmonary Arterial Hypertension in Mice

Increased Nitrosoglutathione Reductase Activity in Hypoxic Pulmonary Hypertension in Mice

Dimethylarginine Dimethylaminohydrolase 1 Deficiency Aggravates Monocrotaline-Induced Pulmonary Oxidative Stress, Pulmonary Arterial Hypertension and Right Heart Failure in Rats.

Cardiomyocyte Dimethylarginine Dimethylaminohydrolase-1 (DDAH1) Plays an Important Role in Attenuating Ventricular Hypertrophy and Dysfunction

[Relationship Between Expression of Endothelial Nitric Oxide Synthase and NADPH Oxidase in Lungs of Mice Exposed to Chronic Hypoxia].

Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction—Molecular Mechanisms and Clinical Significance

Dimethylarginine Dimethylaminohydrolase-1 is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine.

Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine

Ddah1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis

Cardiomyocyte Dimethylarginine Dimethylaminohydrolase1 Attenuates Left-Ventricular Remodeling after Acute Myocardial Infarction: Involvement in Oxidative Stress and Apoptosis.

Dimethylarginine Dimethylaminohydrolase 1 Modulates Endothelial Cell Growth Through Nitric Oxide and Akt

Abstract 5223: Dimethylarginine Dimethylaminohydrolase 1modulates Endothelial Cell Growth and Injury Repair Through No and Akt

DDAH1/ADMA Regulates Adiponectin Resistance in Cerebral Ischemia via the ROS/FOXO1/APR1 Pathway

Repetitive Ischemia Increases Myocardial Dimethylarginine Dimethylaminohydrolase 1 Expression

Phd2 Deficiency Induces Obliterative Vascular Remodeling and Severe Pah Through Nitrative Stress and Caveolin-1 Downregulation

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l-arginine on its metabolism

Abstract 12497: Diminished Cavolin-1 Expression and Augmented Nitrative Stress Secondary to Prolyl-4 Hydroxylase 2 Deficiency Contribute to Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension

Chronic Hypoxia Decreases Endothelial Connexin 40, Attenuates Endothelium‐Dependent Hyperpolarization–Mediated Relaxation in Small Distal Pulmonary Arteries, and Leads to Pulmonary Hypertension

Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE)

ALDH2 (Aldehyde Dehydrogenase 2) Protects Against Hypoxia-Induced Pulmonary Hypertension